Study Stopped
This was a pilot and we achieved the goal with 12 subjects already.
Subtle Energy Transmission and Tao Calligraphy Mindfulness in Telomere Length in Peripheral Blood Leukocytes
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study
1 other identifier
interventional
12
1 country
1
Brief Summary
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study The goal of this Pilot clinical trial is to learn if a Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice works to increase Telomere Length in Peripheral Blood Leukocytes in adults. The main questions it aims to answer are:
- Does A Subtle energy transmission and Tao Calligraphy Mindfulness increase Telomere Length in Peripheral Blood Leukocytes in adults?
- Will this increase of Telomere Length in Peripheral Blood Leukocytes in adults be statistically significant? Researchers will compare the length of Telomere in peripheral blood Leukocytes at beginning of the mindfulness practices to the length of Telomere in peripheral blood Leukocytes at 3 months and at 9 months of regular daily practices. Participants will:
- Receive a transmission of Subtle energy at beginning of practices
- Visit the Laboratory for a blood sample taken at beginning, at 3 months and at 9 months of practices.
- Fill the Study Questionnaires at beginning, at 3 months and at 9 months of practices.
- Practice the Mindfulness with Tao Calligraphy daily 1 hour in the morning and 1 hour in the evening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2023
CompletedFirst Submitted
Initial submission to the registry
April 4, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 25, 2025
CompletedApril 15, 2025
April 1, 2025
1.1 years
April 4, 2024
April 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Telomere Length in Peripheral blood leukocytes
The Change of Telomere Length in Peripheral blood leukocytes after 9 months of Mindfulness Practice with Tao Calligraphy
9 months
Secondary Outcomes (1)
Quality of Life by John Ware's SF-36 Quality of Life questionnaire (that produces eight scores with 0-to-100 scale, 100 being the best possible outcome).
9 months
Study Arms (1)
SIMPLE FOLLOW UP GROUP
OTHEREvery subject who is accepted into the study, will receive prior to the inception of practice transmission of pure energy (blessing) and will be instructed on how to practice meditations with Tao Calligraphy. Blood samples will be drawn at DAP accredited institution in British Columbia (Life Labs or Vancouver Coastal Health) and will be promptly sent by currier to Repeat Diagnostics, All participants will have blood samples drawn and Questionnaire filled at the entry time point (Time 0), at the end of 3 months (Time 1), and at the end of 9 months (Time 2).
Interventions
The unique style of Art Meditation where mindfulness (heightened awareness) is achieved by combination of movement and focus on Chinese Tao Calligraphy while chanting a mantra. The practitioners repeatedly trace the lines of Tao calligraphy with fingers and chant the mantra. This enables them to achieve deep concentration, while maintaining fully alert state. The practice can be done in sitting or standing, depending on the health status and age.
Eligibility Criteria
You may qualify if:
- Adult subjects / patients (age 60 years and over) we expect at 60 years people have already measurable shortening of telomeres
- Healthy or Ill, with the exception of genetic illnesses and cancer (for which treatments could negatively impact telomeres)
- Willingness and ability to comply with data collection requirements.
- Complete submission of required documentation prior to enrollment into the study, including informed consent and consent to release of information.
- Willingness to allow their data to be used for research purposes and published as deemed fit (while conforming to all applicable privacy laws) by Sha Research Foundation.
- Willingness to practice the daily calligraphy meditations and follow the protocol.
You may not qualify if:
- Bipolar disorders, other serious mental disorders (e.g. schizophrenia, psychosis), genetic illnesses (primarily affected chromosomes), and cancer (treatment could negatively impact telomere during research period)
- inability to sign consent and follow instructions
- Unwillingness to participate in data gathering
- Unable to follow the practice regimen, including the daily calligraphy meditations
- Pregnant or nursing. Participants who become pregnant during the study will be required to end their participation. (to avoid any, at current time unknown, potential negative effect of the study on the fetus).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sha Research Foundation (Branch)
North Vancouver, British Columbia, V7R 1P5, Canada
Related Publications (28)
Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, King BG, Shaver PR, Rosenberg EL, Ferrer E, Wallace BA, Saron CD. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology. 2011 Jun;36(5):664-81. doi: 10.1016/j.psyneuen.2010.09.010. Epub 2010 Oct 29.
PMID: 21035949BACKGROUNDDal Lin C, Marinova M, Brugnolo L, Rubino G, Plebani M, Iliceto S, Tona F. Rapid changes of miRNAs-20, -30, -410, -515, -134, and -183 and telomerase with psychological activity: A one year study on the relaxation response and epistemological considerations. J Tradit Complement Med. 2021 Feb 15;11(5):409-418. doi: 10.1016/j.jtcme.2021.02.005. eCollection 2021 Sep.
PMID: 34522635BACKGROUNDPavanello S, Campisi M, Tona F, Lin CD, Iliceto S. Exploring Epigenetic Age in Response to Intensive Relaxing Training: A Pilot Study to Slow Down Biological Age. Int J Environ Res Public Health. 2019 Aug 23;16(17):3074. doi: 10.3390/ijerph16173074.
PMID: 31450859BACKGROUNDThimmapuram J, Pargament R, Sibliss K, Grim R, Risques R, Toorens E. Effect of heartfulness meditation on burnout, emotional wellness, and telomere length in health care professionals. J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):21-27. doi: 10.1080/20009666.2016.1270806. eCollection 2017 Jan.
PMID: 28634520BACKGROUNDLiu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. Correction: A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2019 Feb 25;16(2):e1002760. doi: 10.1371/journal.pmed.1002760. eCollection 2019 Feb.
PMID: 30802240BACKGROUNDLiu Z, Kuo PL, Horvath S, Crimmins E, Ferrucci L, Levine M. A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLoS Med. 2018 Dec 31;15(12):e1002718. doi: 10.1371/journal.pmed.1002718. eCollection 2018 Dec.
PMID: 30596641BACKGROUNDLu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, Hou L, Baccarelli AA, Li Y, Stewart JD, Whitsel EA, Assimes TL, Ferrucci L, Horvath S. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019 Jan 21;11(2):303-327. doi: 10.18632/aging.101684.
PMID: 30669119BACKGROUNDField AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA Methylation Clocks in Aging: Categories, Causes, and Consequences. Mol Cell. 2018 Sep 20;71(6):882-895. doi: 10.1016/j.molcel.2018.08.008.
PMID: 30241605BACKGROUNDGoldman EA, Eick GN, Compton D, Kowal P, Snodgrass JJ, Eisenberg DTA, Sterner KN. Evaluating minimally invasive sample collection methods for telomere length measurement. Am J Hum Biol. 2018 Jan;30(1):10.1002/ajhb.23062. doi: 10.1002/ajhb.23062. Epub 2017 Sep 26.
PMID: 28949426BACKGROUNDAhadi S, Zhou W, Schussler-Fiorenza Rose SM, Sailani MR, Contrepois K, Avina M, Ashland M, Brunet A, Snyder M. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat Med. 2020 Jan;26(1):83-90. doi: 10.1038/s41591-019-0719-5. Epub 2020 Jan 13.
PMID: 31932806BACKGROUNDGorenjak V, Akbar S, Stathopoulou MG, Visvikis-Siest S. The future of telomere length in personalized medicine. Front Biosci (Landmark Ed). 2018 Mar 1;23(9):1628-1654. doi: 10.2741/4664.
PMID: 29293454BACKGROUNDNotterman DA, Schneper L. Telomere Time-Why We Should Treat Biological Age Cautiously. JAMA Netw Open. 2020 May 1;3(5):e204352. doi: 10.1001/jamanetworkopen.2020.4352. No abstract available.
PMID: 32364591BACKGROUNDKoliada AK, Krasnenkov DS, Vaiserman AM. Telomeric aging: mitotic clock or stress indicator? Front Genet. 2015 Mar 16;6:82. doi: 10.3389/fgene.2015.00082. eCollection 2015. No abstract available.
PMID: 25852738BACKGROUNDSanders JL, Newman AB. Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? Epidemiol Rev. 2013;35(1):112-31. doi: 10.1093/epirev/mxs008. Epub 2013 Jan 9.
PMID: 23302541BACKGROUNDVaiserman A, Krasnienkov D. Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives. Front Genet. 2021 Jan 21;11:630186. doi: 10.3389/fgene.2020.630186. eCollection 2020.
PMID: 33552142BACKGROUNDSkytthe A, Pedersen NL, Kaprio J, Stazi MA, Hjelmborg JV, Iachine I, Vaupel JW, Christensen K. Longevity studies in GenomEUtwin. Twin Res. 2003 Oct;6(5):448-54. doi: 10.1375/136905203770326457.
PMID: 14624729BACKGROUNDHerskind AM, McGue M, Holm NV, Sorensen TI, Harvald B, Vaupel JW. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet. 1996 Mar;97(3):319-23. doi: 10.1007/BF02185763.
PMID: 8786073BACKGROUNDvB Hjelmborg J, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M, Kaprio J, Pedersen NL, Christensen K. Genetic influence on human lifespan and longevity. Hum Genet. 2006 Apr;119(3):312-21. doi: 10.1007/s00439-006-0144-y. Epub 2006 Feb 4.
PMID: 16463022BACKGROUNDBoyce WT, Sokolowski MB, Robinson GE. Genes and environments, development and time. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23235-23241. doi: 10.1073/pnas.2016710117.
PMID: 32967067BACKGROUNDSteenman M, Lande G. Cardiac aging and heart disease in humans. Biophys Rev. 2017 Apr;9(2):131-137. doi: 10.1007/s12551-017-0255-9. Epub 2017 Mar 20.
PMID: 28510085BACKGROUNDKalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clin North Am. 2013 Jun;42(2):333-47. doi: 10.1016/j.ecl.2013.02.010. Epub 2013 Mar 22.
PMID: 23702405BACKGROUNDAunan JR, Cho WC, Soreide K. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis. 2017 Oct 1;8(5):628-642. doi: 10.14336/AD.2017.0103. eCollection 2017 Oct.
PMID: 28966806BACKGROUNDKao H Sr, Zhu L, Chao AA, Chen HY, Liu IC, Zhang M. Calligraphy and meditation for stress reduction: an experimental comparison. Psychol Res Behav Manag. 2014 Feb 13;7:47-52. doi: 10.2147/PRBM.S55743. eCollection 2014.
PMID: 24611024BACKGROUNDKao HS, Lam SP, Kao TT. Chinese calligraphy handwriting (CCH): a case of rehabilitative awakening of a coma patient after stroke. Neuropsychiatr Dis Treat. 2018 Jan 31;14:407-417. doi: 10.2147/NDT.S147753. eCollection 2018.
PMID: 29440902BACKGROUNDZhu Z, Wang R, Kao HS, Zong Y, Liu Z, Tang S, Xu M, Liu IC, Lam SP. Effect of calligraphy training on hyperarousal symptoms for childhood survivors of the 2008 China earthquakes. Neuropsychiatr Dis Treat. 2014 Jun 3;10:977-85. doi: 10.2147/NDT.S55016. eCollection 2014.
PMID: 24940061BACKGROUNDWare JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
PMID: 1593914BACKGROUNDWare JE Jr. SF-36 health survey update. Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. doi: 10.1097/00007632-200012150-00008. No abstract available.
PMID: 11124729BACKGROUNDBaerlocher GM, Lansdorp PM. Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH. Cytometry A. 2003 Sep;55(1):1-6. doi: 10.1002/cyto.a.10064.
PMID: 12938182BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Hudoba De Badyn, MD, FRCS
Sha Research Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Research at Sha Research Foundation
Study Record Dates
First Submitted
April 4, 2024
First Posted
April 10, 2024
Study Start
June 15, 2023
Primary Completion
July 31, 2024
Study Completion
March 25, 2025
Last Updated
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- September 2024 to March 2025
- Access Criteria
- Anyone on Clinical Trials Gov
Will need to contact IRB if permitted, as this is not in approved protocol